Follicular Lymphoma Clinical Trials

• Participant must be at least 18 years of age, inclusive, at the time of signing the ICF.

• Histologically confirmed diagnosis of classic FL per WHO 2022 classification

• ECOG performance status of 0 to 2

• No prior systemic lymphoma-directed therapy

• Need for systemic treatment meeting at least 1 GELF criteria

• FDG-avid and measurable disease

• Stage II to IV and FLIPI 2-5 \[Phase III only\]

• Adequate liver, hematological, renal and cardiac function.

⁃ The above is a summary, other inclusion criteria details may apply